Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01334749 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Observational Study on Determinants of Dementia After Stroke

Study acronym: DEDEMAS
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Publications: 6 to 7v15
  2. 3 versions Re-verified since Oct 1, 2020, no change to tracked fieldsv12-v14
  3. Primary completion date: Apr 2028 to Jan 2029v11 Show 7 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 600 to confirmed 736
    • Study completion date: Aug 2028 to Jan 2029
    • Secondary endpoints: 6 to 7
    • Study description expanded, about 14 words
    • Site details revised at 5 of 5 sites
    • Eligibility criteria expanded, about 2 words
  4. Primary completion date: Apr 2019 to Apr 2028v10 Show 4 more changesShow less
    • Primary endpoints: 1 to 2
    • Study sites: 1 to 5
    • Study completion date: Aug 2019 to Aug 2028
    • Publications: 5 to 6
  5. Primary completion date: Apr 2016 to Apr 2019
    • Study completion date: Apr 2019 to Aug 2019
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Re-verified, no change to tracked fieldsv8
  2. Eligibility criteria shortened, about 9 words
    • Site contact updated
    v7
  3. Primary completion date: Apr 2014 to Apr 2016v6
  4. Re-verified, no change to tracked fieldsv5
  5. Publications: details revised at 1 of 5 entriesv4
  6. Study description expanded, about 20 wordsv3
  7. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Apr 2014
    • Study completion date: Apr 2019
    • Secondary endpoints: 4 to 6
    • Site details revised
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary aim of the DEDEMAS (Determinants of Dementia After Stroke) study is to identify predictors of post stroke dementia (PSD). A particular focus will be on biological markers (neuroimaging, biochemical markers derived from blood) and on interactions between vascular and neurodegenerative mechanisms. For this purpose patients with an acute stroke and without prior dementia will be followed for 10 years. Note: Starting from 01.01.2014 this study is expanded to a multi-centric design funded by the German Center for Neurodegenerative Diseases (The DZNE - Mechanisms of Dementia After Stroke (DEMDAS) Study). This includes the following study sites: DZNE/München - Institute for Stroke and Dementia Research, Klinikum der Universität München (Coordinator); DZNE/Berlin - Neuroscience Research Center - Campus Mitte Charité; DZNE/Bonn - Klinik und Poliklinik für Neurologie, Universitätsklinikum Bonn; DZNE/Göttingen - University Medical Center Göttingen; DZNE/Magdeburg - Universitätsklinikum Magdeburg.
Trial Details
NCT Number NCT01334749
Lead Sponsor Ludwig-Maximilians - University of Munich
Conditions
(from sponsor)		 Ischemic Stroke, Hemorrhagic Stroke
Related terms Alzheimer Disease, Brain Ischemia, Dementia, Dementia, Vascular, Hemorrhagic Stroke, Intracranial Hemorrhages, Ischemic Stroke, Stroke
Enrollment 736 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov